血管紧张素转换酶基因型与卡托普利疗效的相关性研究  

Correlation of Angiotensin Converting Enzyme Genes Type with the Effect Antihypertensive treatment by Captopril

作　　者：吴寿领 冯绍儒 李可兵 郑小明 高明 郝冰 洪江 刘国仗[2] 刘力生[2] 

机构地区：[1]开滦矿务局医院,河北唐山063000 [2]北京阜外医院,北京100037

出　　处：《高血压杂志》2001年第4期296-297,共2页Chinese Journal of Hypertension

摘　　要：目的　研究原发性高血压患者ACE基因多态性分布与卡托普利疗效的相关性。方法　 133名原发性高血压患者按ACE基因多态性的II ,ID与DD型三种 ,同时服用卡托普利 2 5mgbid ,服药前后作动态血压监测 ,以观察在各种不同ACE基因多态性间的区别。结果　ID型患者在 2 4小时收缩压 ,白天收缩压及夜间收缩压的降低程度均较其它型为明显 (P <0 0 5 )。结论Objective To study the correlation of angiotensin converting enzyme genes type with the effect of antihypertension treatment by captopril. Methods Angiotensin converting enzyme genes I/D polymorphism were examined by polymerase chain reaction(PCR) in 133 patients with essential hypertension. Ambulatory blood pressure was measured before and after taking captopril 25 mg bid for 4 weeks. Results The reduction in 24 hSBP,dSBP,and nSBP in ID genetype was greater than that in II or DD genetype( P <0 05). Conclusion Captopril is may be more appropriate for the hypertensive patients with fit ACE I/D gene type.

关 键 词：原发性高血压 转换酶抑制剂 疗效 ACE基因多态性 卡托普利 

分 类 号：R972[医药卫生—药品]